Insilico Medicine
Baltimore, US · Founded 2014 · Delaware corporation · 5 known investors
Uses artificial intelligence innovations to bridge biomarker development and drug discovery.
Founders & leadership
AZ
Aleksandrs ZavoronkovsExecutive Officer, Director
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$6MraisedJun 2018 · 15 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex ZhavoronkovExecutive Officer, Director
- James MellonDirector
- Qingsong ZhuExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedJul 2017 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJul 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.8MraisedJul 2017 · 17 investors · BiotechnologyRule 506(b)
▶$2.8MraisedJul 2017 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $25K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.